Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Ovarian hyperstimulation closely associated with resumption of follicular growth after chemotherapy during tamoxifen treatment in premenopausal women with breast cancer: a multicenter retrospective cohort study

Fig. 2

Therapeutic schedules with or without adjuvant therapy such as chemotherapy and Gn-RH analog treatment. The recruited patients were classified into 4 groups based on pre- or post-operative adjuvant therapies: group a (n = 26), treated with TAM alone; group b (n = 63), TAM treatment after 2-year- combined therapy with a Gn-RH agonist; group c (n = 110), TAM treatment after chemotherapy; group d (n = 36), 5-year-combined therapy with TAM and a Gn-RH agonist. In group b, clinical evaluation was started just after the end of 2-year-Gn-RH analog treatment, while the evaluation in group d was initiated from the start of Gn-RH analog treatment (black arrows). Black arrows, the start of evaluation

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us